C. Dowding

1.4k total citations
28 papers, 1.1k citations indexed

About

C. Dowding is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, C. Dowding has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 15 papers in Genetics and 7 papers in Oncology. Recurrent topics in C. Dowding's work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Acute Myeloid Leukemia Research (11 papers). C. Dowding is often cited by papers focused on Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Acute Myeloid Leukemia Research (11 papers). C. Dowding collaborates with scholars based in United Kingdom and United States. C. Dowding's co-authors include John M. Goldman, Graham P. Riley, M. Y. Gordon, Mel Greaves, AP Guo, M. Y. Gordon, Martin Siczkowski, Goldman Jm, Melvyn F. Greaves and Jill Hibbin and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

C. Dowding

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Dowding United Kingdom 15 886 536 184 170 167 28 1.1k
LB To Australia 12 894 1.0× 267 0.5× 370 2.0× 38 0.2× 251 1.5× 17 1.4k
JM Cayuela France 19 887 1.0× 348 0.6× 250 1.4× 173 1.0× 519 3.1× 24 1.4k
Gisella Volpe Italy 20 364 0.4× 257 0.5× 356 1.9× 59 0.3× 371 2.2× 37 1.1k
Ruth Seggewiss Germany 16 722 0.8× 384 0.7× 374 2.0× 200 1.2× 322 1.9× 26 1.4k
T Leemhuis United States 18 753 0.8× 287 0.5× 256 1.4× 43 0.3× 317 1.9× 27 1.2k
MA Bitter United States 11 661 0.7× 334 0.6× 292 1.6× 41 0.2× 301 1.8× 18 1.1k
A. Delforge Belgium 16 327 0.4× 473 0.9× 212 1.2× 36 0.2× 256 1.5× 49 1.0k
Il‐Kang Na Germany 22 520 0.6× 275 0.5× 437 2.4× 83 0.5× 374 2.2× 69 1.4k
GW Dewald United States 9 673 0.8× 354 0.7× 169 0.9× 41 0.2× 314 1.9× 11 835
T.J. Hamblin United Kingdom 20 558 0.6× 791 1.5× 220 1.2× 60 0.4× 334 2.0× 37 1.7k

Countries citing papers authored by C. Dowding

Since Specialization
Citations

This map shows the geographic impact of C. Dowding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Dowding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Dowding more than expected).

Fields of papers citing papers by C. Dowding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Dowding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Dowding. The network helps show where C. Dowding may publish in the future.

Co-authorship network of co-authors of C. Dowding

This figure shows the co-authorship network connecting the top 25 collaborators of C. Dowding. A scholar is included among the top collaborators of C. Dowding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Dowding. C. Dowding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dowding, C., et al.. (1993). Potential Mechanisms of Action of Interferon-αin CML. Leukemia & lymphoma. 11(sup1). 185–191. 30 indexed citations
2.
Fabritiis, Paolo de, C. Dowding, J Bungey, et al.. (1993). Phenotypic Characterization of Normal and CML CD34–Positive Cells: Only the Most Primitive CML Progenitors Include Ph-neg Cells. Leukemia & lymphoma. 11(1-2). 51–61. 4 indexed citations
3.
Weide, Rudolf, et al.. (1991). Inactivation of the retinoblastoma susceptibility gene in a human high grade non‐Hodgkin's lymphoma cell line. British Journal of Haematology. 78(4). 500–505. 10 indexed citations
4.
Dowding, C., AP Guo, Diane Maisin, M. Y. Gordon, & John M. Goldman. (1991). The effects of interferon‐α on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M‐BCR breakpoint. British Journal of Haematology. 77(2). 165–171. 26 indexed citations
5.
6.
Dowding, C., et al.. (1991). Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.. PubMed. 19(5). 326–31. 14 indexed citations
7.
Martiat, Philippe, Susheela Dhut, Tracy Chaplin, et al.. (1990). Inhibition of P210BCR/ABL Expression in K562 Cells by Electroporation with an Antisense Oligonucleotide. Leukemia & lymphoma. 3(3). 201–208. 15 indexed citations
8.
Jaubert, J., Philippe Martiat, C. Dowding, Norbert Ifrah, & John M. Goldman. (1990). The position of the M‐BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukaemia. British Journal of Haematology. 74(1). 30–35. 45 indexed citations
9.
Gordon, M. Y., et al.. (1990). Haemopoietic stem cell subpopulations in mouse and man: discrimination by differential adherence and marrow repopulating ability.. PubMed. 5 Suppl 1. 6–8. 11 indexed citations
10.
Weide, Rudolf, et al.. (1990). The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia.. PubMed. 4(10). 695–9. 27 indexed citations
11.
Brito‐Babapulle, F., Stella Bowcock, Robert Marcus, et al.. (1989). Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. British Journal of Haematology. 73(1). 76–81. 65 indexed citations
12.
Marsh, J. C. W., et al.. (1989). Recurrent graft failure following syngeneic bone marrow transplantation for aplastic anaemia.. PubMed. 4(5). 581–5. 6 indexed citations
13.
Brito‐Babapulle, F., et al.. (1987). Complete remission after autografting for chronic myeloid leukaemia. Leukemia Research. 11(12). 1115–1117. 20 indexed citations
14.
Gordon, M. Y., C. Dowding, Graham P. Riley, & Melvyn F. Greaves. (1987). Characterisation of stroma‐dependent blast colony‐forming cells in human marrow. Journal of Cellular Physiology. 130(1). 150–156. 60 indexed citations
15.
Ganesan, TS, Feyruz V. Rassool, AP Guo, et al.. (1986). Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood. 68(4). 957–960. 76 indexed citations
16.
17.
Hast, Robert, C. Dowding, Tadeusz Robak, & JM Goldman. (1986). Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.. PubMed. 14(10). 981–7. 3 indexed citations
18.
Martin, Hans, Jill Hibbin, C. Dowding, et al.. (1986). Purification of haemopoietic progenitor cells from patients with chronic granulocytic leukaemia using Percoll density gradients and elutriation. British Journal of Haematology. 63(1). 187–198. 11 indexed citations
19.
Gordon, M. Y., et al.. (1985). Separation of human blast progenitors from granulocytic, erythroid, megakaryocytic, and mixed colony-forming cells by "panning" on cultured marrow-derived stromal layers.. PubMed. 13(9). 937–40. 31 indexed citations
20.
Dowding, C., K. H. Th'ng, J M Goldman, & D. A. G. Galton. (1984). Increased T-lymphocyte numbers in chronic granulocytic leukemia before treatment.. PubMed. 12(10). 811–15. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LB To Breakdown of academic impact, for papers by JM Cayuela Breakdown of academic impact, for papers by Gisella Volpe Breakdown of academic impact, for papers by Ruth Seggewiss Breakdown of academic impact, for papers by T Leemhuis Breakdown of academic impact, for papers by MA Bitter Breakdown of academic impact, for papers by A. Delforge Breakdown of academic impact, for papers by Il‐Kang Na Breakdown of academic impact, for papers by GW Dewald Breakdown of academic impact, for papers by T.J. Hamblin
Rankless by CCL
2026